Document is current
Any future updates will be listed below
-
Authors
Fadzil, Muhammad Fakhrurazi Ahmad https://orcid.org/0000-0003-4675-3078
Ashhar, Zarif https://orcid.org/0000-0001-5057-4705
Kasbollah, Azahari https://orcid.org/0000-0002-7157-7822
Safee, Zaitulhusna Md
Jamaludin, Siti Fazira Edzua
Al-Ibraheem, Akram https://orcid.org/0000-0002-0978-4716
- License Information
-
More Information
Article History
Received: 29 June 2025
Revised: 7 October 2025
Accepted: 8 October 2025
First Online: 29 October 2025
Declarations
:
: This study does not involve any human participants, human data, or human biological material. It is a narrative review and therefore does not require ethics approval or informed consent.
: Not applicable.
: During the preparation of this work, the authors used ChatGPT (OpenAI) for language refinement, including grammar checking and proofreading. Following the use of this tool, the authors thoroughly reviewed and edited the content to ensure accuracy and appropriateness. The authors take full responsibility for the integrity and content of the final publication.
: Muhammad Fakhrurazi Ahmad Fadzil and Akram Al-Ibraheem serves as the National Counterpart in the IAEA RAS6111 project which aim to enhance the management of cancer through capacity buildings in theranostics within the region.
: This manuscript has not been posted on any preprint server.
: Not applicable.
: Akram Al-Ibraheem is an editorial board member of Nuclear Medicine and Molecular Imaging. Muhammad Fakhrurazi Ahmad Fadzil, Zarif Ashhar, Azahari Kasbollah, Zaitulhusna Md Safee and Siti Fazira Edzua Jamaludin declare that they have no conflict of interest.
